Tigecycline | Imipenem/cilastatin | Difference (Tigecycline-Imipenem/cilastatin) | |||
---|---|---|---|---|---|
Population | N | % (95% CI) | N | % (95% CI) | % (95% CI) |
ME | 45/52 | 86.5 (74.2, 94.4) | 47/48 | 97.9 (88.9, 99.9) | -11.4 (-23.5, 0.7) |
Monomicrobial | 30/33 | 90.9 (75.7, 98.1) | 25/26 | 96.2 (80.4, 99.9) | -5.2 (-22.0, 13.7) |
Polymicrobial | 15/19 | 78.9 (54.4, 93.9) | 22/22 | 100.0 (84.6, 100.0) | -21.1 (-46.1, 2.2) |
m-mITT | 49/60 | 81.7 (69.6, 90.5) | 50/55 | 90.9 (80.0, 97.0) | -9.2 (-23.4, 4.9) |
Monomicrobial | 32/38 | 84.2 (68.7, 94.0) | 27/29 | 93.1 (77.2, 99.2) | -8.9 (-26.0, 10.7) |
Polymicrobial | 17/22 | 77.3 (54.6, 92.2) | 23/26 | 88.5 (69.8, 97.6) | -11.2 (-35.8, 13.0) |
CE | 67/77 | 87.0 (77.4, 93.6) | 83/87 | 95.4 (88.6, 98.7) | -8.4 (-18.3, 1.5) |
c-mITT | 78/97 | 80.4 (71.1, 87.8) | 88/98 | 89.8 (82.0, 95.0) | -9.4 (-20.3, 1.6) |